Cibus, Inc.

US$1.18As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CBUSHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (48.34%)
Div yield —
ROE (223.16%)
Biotechnology
Beta (5Y) 1.64
PE TTM —
TSR TTM (26.25%)
Mkt cap US$90.19M
ROIC (10.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.14
(3.73%)
(32.21%)
Hold 1|2|3|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
35.66%
33.42%
23.48%
27.63%
Revenue$M
8.096
8.535
8.910
9.217
2.46%
9.41%
13.16%
13.87%
Peers (US$90.19M)
Cap (US$)
PE
90.26M
—
Capital
TTM
5Y
10Y
Leveragex
0.863
0.206
0.164
EBIT/Intx
2.021
0.890
0.738
Own earn%
(4.06)
61.83
67.10
Sh yield%
36.12
49.65
50.66
Owners
Insiders/Inst%
2.77
66.54
Short interest%
1.18
SBC / revenue%
1.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
9–14
$1 testx
0.0
Incr. ROIC%
19